Stem Point Capital LP Rhythm Pharmaceuticals, Inc. Transaction History
Stem Point Capital LP
- $401 Billion
- Q4 2024
A detailed history of Stem Point Capital LP transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 208,016 shares of RYTM stock, worth $11.1 Million. This represents 2.91% of its overall portfolio holdings.
Number of Shares
208,016
Previous 41,268
404.06%
Holding current value
$11.1 Million
Previous $2.16 Billion
438.6%
% of portfolio
2.91%
Previous 0.65%
Shares
2 transactions
Others Institutions Holding RYTM
# of Institutions
216Shares Held
64.4MCall Options Held
445KPut Options Held
26.6K-
Black Rock Inc. New York, NY6.74MShares$359 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$350 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$324 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$324 Million3.77% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$196 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.97B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...